The hottest pharmaceutical packaging industry face

  • Detail

The pharmaceutical packaging industry is facing the challenge of restructuring

recently, with the introduction of a series of policies and regulations issued by the state to find a sustainable driving force for the overall transformation and upgrading of the manufacturing industry, and strengthen the rectification and standardization of pharmaceutical packaging, the pharmaceutical packaging market has also ushered in a spring of development

divide up 20billion yuan "cake"

according to the survey, the annual growth rate of China's pharmaceutical packaging industry is more than 10%, but it can only meet about 80% of the needs of domestic pharmaceutical enterprises, and 65% of China's pharmaceutical packaging level is still behind the world average level in the 1980s. The quality of packaging materials is very low, and its contribution to the pharmaceutical industry is even weaker. In developed countries, packaging accounts for 30% of the value of drugs, while in China, this value is 10% lower. According to the development speed of China's pharmaceutical industry in recent years, the annual GDP of drug packaging materials will quickly exceed 20billion yuan in the short term

Pu Jinbo, deputy general manager of Nanfang Packaging Co., Ltd., revealed that by the end of 2003, China's pharmaceutical packaging material manufacturers and their raw material suppliers had ordered 24 PET production lines from the above three companies. This number seems small, but it is actually quite amazing, because PET film is the main raw material of composite film for pharmaceutical packaging, and launching a large PET production line costs tens of millions of dollars at any time. "No enterprise dares to invest money in it easily, which shows how attractive the potential of China's pharmaceutical packaging industry is."

disorderly competition hinders the drug packaging investment

20 billion yuan cake, and getting part of it will make enterprises happy. However, the existing problems of many drug packaging enterprises make it impossible for drug packaging enterprises to be so proud of the market

"except for a few large-scale enterprises with relatively standardized quality management, there are many workshop enterprises in the overall pharmaceutical hollow capsule industry, and inferior products are full of them." Yuanxingrong, the R & D Manager of Shanghai chunzhitang biological products company, a health food enterprise that produces garlic oil soft capsules, told

Xinchang County, Zhejiang Province is known as the "hometown of capsules" in China, and its annual output once accounted for 1/3 of the country in the 1980s. However, among the 327 capsule production enterprises in Xinchang County, there are 299 unlicensed enterprises, 90% of which are in the "low, small and scattered" business situation, of which more than 40% of the capsule production enterprises belong to individual enterprises, and family workshops occupy the dominant position

these illegal manufacturers' unauthorized production of drug packaging materials without certification has brought a huge impact on those formal enterprises. According to insiders, the cost of the same composite membrane produced in the clean workshop is about 22000 yuan/ton; However, those produced in the "underground factory" cost no more than 18000 yuan/ton. In order to reduce product costs, some non-standard pharmaceutical enterprises secretly buy a large number of low-cost and low-quality products, which has seriously damaged the interests of many regular pharmaceutical packaging material manufacturers

we should regularly adhere to whether the screws in various parts can be stable. Li Yongan, general manager of Lianyungang Zhongjin pharmaceutical packaging Co., Ltd., also told, "although there is a huge market potential in the pharmaceutical packaging market, we still need to make a careful decision." Since China has not met the requirements of green technology, most of the existing pharmaceutical packaging material production enterprises are township collective enterprises, which are small in scale, and the personnel quality, equipment, technology and management can be displayed through digital displays or PCs. the result level is low, and the unstable product quality causes disorderly competition. Their companies are seeking diversified development, turning to explore packaging opportunities in the food industry, while the expansion of pharmaceutical packaging production, It also needs to wait for the country to further rectify and standardize the market

Copyright © 2011 JIN SHI